A doctor will review your order and write you a prescription, if appropriate. This prescription is then forwarded to a pharmacy. The pharmacy will have your medicine delivered to you within one to three working days. Read more about this process here.

Instruction costs (includes consult & service fee)
Service – Instruction costs (includes consult & service fee)

What is Anoro 55/22 ug? 

Anoro 55 ug / 22 ug is a bronchodilator.  

What is Anoro 55/22 ug used for? 

Anoro 55/22 ug is used to relive symptoms of chronic obstructive pulmonary disease in adults. Anoro 55/22 ug is a combination inhaled LABA/LAMA respiratory medication. This means that both compounds act locally on airways to produce bronchodilation following oral inhalation. 

How to take Anoro 55/22 ug? 

Anoro 55/22 ug is administered via an ELLIPTA inhaler containing a pre-dispensed dose (the dose leaving the mouthpiece of the inhaler). Anoro 55/22 ug should be inhaled once daily at the same time each day (this helps to maintain bronchodilation).  


Each single inhalation provides a set delivered dose of 65 ug umeclidinium bromide which is equivalent to 55 ug of umeclidinium and 22 ug of vilanterol (as trifenatate).  

Side effects 

The most common side effects experienced when being treated with Anoro 55/22 ug include:  

  • Urinary tract infection;  
  • Sinusitis;  
  • Nasopharyngitis/pharyngitis;  
  • Upper respiratory tract infection  
  • Headache  
  • Cough;  
  • Oropharyngeal pain;  
  • Constipation;  
  • Dry mouth.  

Less common side effects include:  

  • Rash;  
  • Tremor;  
  • Dysgeusia;  
  • Atrial fibrillation;  
  • Supraventricular tachycardia;  
  • Rhythm idioventricular;  
  • Tachycardia;  
  • Supraventricular extrasystoles;  
  • Palpitations;  
  • Dysphonia.   

See the package leaflet for more information on side effects.  

Who should not use Anoro 55/22 ug? 

Anoro 55/22 ug should not be used in people with hypersensitivity to any of the ingredients. Anoro 55/22 ug is not suitable for treating acute episodes of bronchospasm. Anoro 55/22 ug should not be used by patients with asthma as it has not been investigated in this population.  

Pregnancy/ driving ability / alcohol 

Anoro 55/22 ug should be used in caution in women who are pregnant or breastfeeding if their healthcare professional deems the benefits outweigh the risks. There are no data on the effects of Anoro 55/22 ug on fertility.  
There is no evidence to suggest that Anoro 55/22 ug affects driving ability or use of machinery.  
Anoro 55/22 ug is not thought to interact with alcohol.